Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 9 (2), 199-228
- https://doi.org/10.3109/08982109909024786
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Biosynthetically lipid‐modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomesFEBS Letters, 1996
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Active targeting with particulate carrier systems in the blood compartmentAdvanced Drug Delivery Reviews, 1995
- Molecular and Cellular Mechanisms of Receptor-Mediated EndocytosisDNA and Cell Biology, 1991
- Optimization and Upscaling of Doxorubicin-Containing Liposomes for Clinical UseJournal of Pharmaceutical Sciences, 1990
- Regulatory role of CD19 molecules in B-cell activation and differentiationCellular Immunology, 1989
- Vesicles of variable sizes produced by a rapid extrusion procedureBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- Liposome-Cell Interaction: Transfer and Intracellular Release of a Trapped Fluorescent MarkerScience, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- AN ELECTRON-TRANSPORT SYSTEM ASSOCIATED WITH THE OUTER MEMBRANE OF LIVER MITOCHONDRIAThe Journal of cell biology, 1967